REZPEGALDESLEUKIN, NOVEL TREG-INDUCING THERAPY, DEMONSTRATES EFFICACY IN ATOPIC DERMATITIS AND ASTHMA IN PHASE 2B TRIALJonathan Corren, David Rosmarin, Jonathan I. Silverberg et al.|Annals of Allergy Asthma & Immunology|2025Cited by 1